Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Symptoms and signs  





2 Diagnosis  





3 Treatment  





4 Prognosis  





5 Epidemiology  





6 History  





7 References  





8 External links  














Acute interstitial pneumonitis






العربية
Deutsch
Español
Français
Italiano
Polski
Português
Русский
Slovenčina
Українська

 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 

(Redirected from HammanRich syndrome)

HR syndrome
Other namesAcute interstitial pneumoniaorHamman–Rich syndrome
Micrographofdiffuse alveolar damage, the histologic correlate of acute interstitial pneumonitis. H&E stain.
SpecialtyPulmonology Edit this on Wikidata

Acute interstitial pneumonitis (also known as acute interstitial pneumonia) is a rare, severe lung disease that usually affects otherwise healthy individuals. There is no known cause or cure.

Acute interstitial pneumonitis is often categorized as both an interstitial lung disease and a form of acute respiratory distress syndrome (ARDS). In uncommon instances, if ARDS appears acutely, in the absence of known triggers, and follows a rapidly progressing clinical course, the term "Acute interstitial pneumonia" is used.[1] ARDS is distinguished from the chronic forms of interstitial pneumonia such as idiopathic pulmonary fibrosis.[2]

Symptoms and signs[edit]

The most common symptoms of acute interstitial pneumonitis are highly productive cough with expectoration of thick mucus, fever, and difficulties breathing. These often occur over a period of one to two weeks before medical attention is sought. The presence of fluid means the person experiences a feeling similar to 'drowning'. Difficulties breathing can quickly progress to an inability to breathe without support (respiratory failure).[citation needed]

Acute interstitial pneumonitis typically progresses rapidly, with hospitalization and mechanical ventilation often required only days to weeks after initial symptoms of cough, fever, and difficulties breathing develop.[citation needed]

Diagnosis[edit]

Rapid progression from initial symptoms to respiratory failure is a key feature. An X-ray that shows ARDS is necessary for diagnosis (fluid in the small air sacs (alveoli) in both lungs). In addition, a biopsy of the lung that shows organizing diffuse alveolar damage is required for diagnosis. This type of alveolar damage can be attributed to nonconcentrated and nonlocalized alveoli damage, marked alveolar septal edema with inflammatory cell infiltration, fibroblast proliferation, occasional hyaline membranes, and thickening of the alveolar walls. The septa are lined with atypical, hyperplastic type II pneumocytes, thus leading to the collapse of airspaces. Other diagnostic tests are useful in excluding other similar conditions, but history, X-ray, and biopsy are essential. These other tests may include basic blood work, blood cultures, and bronchoalveolar lavage.[citation needed]

The clinical picture is similar to ARDS, but AIP differs from ARDS in that the cause for AIP is not known.

Treatment[edit]

Treatment is primarily supportive. Management in an intensive care unit is required and the need for mechanical ventilation is common. Therapy with corticosteroids is generally attempted, though their usefulness has not been established. The only treatment that has met with success to date is a lung transplant.[citation needed]

Prognosis[edit]

Sixty percent of people with acute interstitial pneumonitis will die in the first six months of illness.[3] The median survival is 1+12 months. However, most people who have one episode do not have a second. People who survive often recover lung function completely.[citation needed]

Epidemiology[edit]

Acute interstitial pneumonitis occurs most frequently among people older than forty years old. It affects men and women equally. There are no known risk factors; in particular, smoking is not associated with increased risk.[citation needed]

History[edit]

Acute interstitial pneumonitis was first described in 1935 by Louis Hamman and Arnold Rich, and given the name Hamman–Rich syndrome.[4]

References[edit]

  1. ^ Robbin's Pathological Basis of Disease.
  • ^ Hamman L.; Rich A.R. (1944). "Acute diffuse interstitial fibrosis of the lungs". Bull. Johns Hopkins Hosp. 74: 177–212.
  • ^ Bouros, D; Nicholson AC; Polychronopoulos V; du Bois RM (2000). "Acute interstitial pneumonia". Eur. Respir. J. 15 (2): 412–8. doi:10.1034/j.1399-3003.2000.15b31.x. PMID 10706513.
  • ^ Hamman, L; Rich AR (1935). "Fulminating diffuse interstitial fibrosis of the lungs". Transactions of the American Clinical and Climatological Association. 51. European Respiratory Society: 154–163. PMC 2242096. PMID 21407504.
  • External links[edit]



    Retrieved from "https://en.wikipedia.org/w/index.php?title=Acute_interstitial_pneumonitis&oldid=1214034297"

    Categories: 
    Respiratory diseases principally affecting the interstitium
    Ailments of unknown cause
    Syndromes affecting the lung
    Hidden categories: 
    Articles needing additional references from June 2021
    All articles needing additional references
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from November 2020
    Articles with unsourced statements from December 2020
    Articles with BNF identifiers
    Articles with BNFdata identifiers
     



    This page was last edited on 16 March 2024, at 15:53 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki